Whitehawk Therapeutics's three largest insider shareholders as of May 30, 2026 are Behzad Aghazadeh (Director, 3.47Mn shares), Anupam Dalal (Director, 3.41Mn shares), Caley Castelein (Director, 2.17Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Steven Prelack | - | 24,485 | 0 | 02 Jul, 2021 |
| Caley Castelein | - | 0 | 2,165,998 | 04 Mar, 2025 |
| Anupam Dalal | - | 0 | 3,410,402 | 04 Mar, 2025 |
| Pravin Dugel | - | 12,568 | 0 | 02 Jul, 2021 |
| Behzad Aghazadeh | - | 0 | 3,471,752 | 26 Sep, 2022 |
| Brendan Delaney | Chief Operating Officer | 20,000 | 0 | 27 Sep, 2022 |
| Scott M. Giacobello | Chief Financial Officer | 295,224 | 0 | 17 Apr, 2026 |
| Bryan Ball | - | 572,551 | 0 | 03 Apr, 2026 |
| Neil Desai | Executive Chairman | 0 | 1,411,543 | 04 Mar, 2024 |
| David James Lennon | Chief Executive Officer | 518,622 | 0 | 10 Apr, 2026 |
| Baiteng Zhao | - | 0 | 1,250,000 | 04 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Apr, 2026 | Scott M. Giacobello | Common Stock | D | 77,000 | $3.86 | 436,824 | D | S |
| 16 Apr, 2026 | Scott M. Giacobello | Common Stock | D | 141,600 | $4.13 | 295,224 | D | S |
| 09 Apr, 2026 | David James Lennon | Common Stock | D | 14,500 | $3.38 | 518,622 | D | S |
| 06 Apr, 2026 | David James Lennon | Common Stock | D | 102,395 | $3.51 | 691,154 | D | S |
| 07 Apr, 2026 | David James Lennon | Common Stock | D | 94,087 | $3.43 | 597,067 | D | S |
| 08 Apr, 2026 | David James Lennon | Common Stock | D | 63,945 | $3.40 | 533,122 | D | S |
| 01 Apr, 2026 | Scott M. Giacobello | Common Stock | A | 473,902 | - | 502,002 | D | M |
| 01 Apr, 2026 | David James Lennon | Common Stock | A | 775,828 | - | 820,407 | D | M |
| 01 Apr, 2026 | Margaret Dugan | Stock Option (right to buy) | A | 283,157 | $0.00 | 283,157 | D | A |
| 01 Apr, 2026 | David Dornan | Stock Option (right to buy) | A | 282,340 | $0.00 | 282,340 | D | A |
| 01 Apr, 2026 | Bryan Ball | Common Stock | A | 366,532 | - | 572,551 | D | M |
| 02 Apr, 2026 | David James Lennon | Common Stock | D | 26,858 | $3.48 | 793,549 | D | S |
| 01 Apr, 2026 | Bryan Ball | Restricted Stock Units | D | 366,532 | $0.00 | 0 | D | M |
| 01 Apr, 2026 | Scott M. Giacobello | Restricted Stock Units | D | 473,902 | $0.00 | 0 | D | M |
| 01 Apr, 2026 | David James Lennon | Restricted Stock Units | D | 775,828 | $0.00 | 0 | D | M |
| 01 Apr, 2026 | Bryan Ball | Stock Option (right to buy) | A | 250,058 | $0.00 | 250,058 | D | A |
| 01 Apr, 2026 | Scott M. Giacobello | Stock Option (right to buy) | A | 300,677 | $0.00 | 300,677 | D | A |
| 01 Apr, 2026 | David James Lennon | Stock Option (right to buy) | A | 831,148 | $0.00 | 831,148 | D | A |
| 01 Mar, 2026 | David James Lennon | Common Stock | A | 16,250 | - | 49,679 | D | M |
| 01 Mar, 2026 | Scott M. Giacobello | Common Stock | A | 6,750 | - | 30,694 | D | M |